Therefore, investigating the etiological factors and pathogenesis of HER2-positive breast cancer, as well as developing and implementing effective intervention and treatment strategies, have consistently been the central research objectives in the field of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.